研究乳腺癌诊断后 12 个月内的康复利用与第二年（诊断后 12 - 24 个月）的自付费用之间的关联。对 2009-2019 年监测、流行病学和最终结果与医疗保险相关的二次分析数据库。接受康复服务的个人与未接受服务的个人进行倾向评分匹配。使用具有伽玛分布的广义线性模型对总体模型和医疗保健服务特定模型进行了检查。美国的住院和门诊医疗机构参与者：：35,212 名被诊断患有非转移性乳腺癌并连续参加医疗保险收费服务的个人（A、B 和 D 部分）在诊断前 12 个月和诊断后 24 个月内。不适用 主要结果指标：：个人成本责任，自付费用的代表，其定义为免赔额、共同保险以及诊断后第二年（诊断后 12 - 24 个月）期间的共付额。与未进行康复治疗的个人相比，接受康复治疗的个人的平均个人成本责任较高（4,013 美元 vs. 3,783 美元），尽管这不是临床上的一项研究。有意义的差异（d=0.06）。接受康复服务的个人的个人护理费用（1,634 美元 vs. 1,476 美元）、机构门诊费用（886 美元 vs. 812 美元）和处方药费用（959 美元 vs. 906 美元）显着较高，而机构住院费用则显着降低（455 美元对 504 美元），以及耐用医疗设备（81 美元对 86 美元）。与未接受康复服务的乳腺癌老年患者相比，接受康复服务的乳腺癌老年患者在诊断后第二年承担的费用更高。未来的工作需要研究较长时间内康复与自付费用之间的关系以及感知效益。版权所有 © 2024。由 Elsevier Inc. 出版。

To examine the association between rehabilitation utilization within 12 months of breast cancer diagnosis and out-of-pocket costs in the second year (12 - 24 months following diagnosis).Secondary analysis of the 2009-2019 Surveillance, Epidemiology and End Results-Medicare linked database. Individuals who received rehabilitation services were propensity-score matched to individuals who did not receive services. Overall and health care service-specific models were examined using generalized linear models with a gamma distribution.Inpatient and outpatient medical facilities in the United States PARTICIPANTS: : 35,212 individuals diagnosed with non-metastatic breast cancer and were continuously enrolled in Medicare Fee-For Service (parts A, B, and D) in the 12 months prior to and 24 months post- diagnosis.Not applicable MAIN OUTCOME MEASURES: : Individual cost responsibility, a proxy for out-of-pocket costs, which was defined as deductibles, coinsurance, and copayments during the second year following diagnosis (12 - 24 months post- diagnosis).The mean individual cost responsibility was higher in individuals who utilized rehabilitation compared to those who did not ($4,013 vs. $3,783), although it was not a clinically meaningful difference (d=0.06). Individuals who received rehabilitative services had significantly higher costs attributed to individual provider care ($1,634 vs. $1,476), institutional outpatient costs ($886 vs. $812), and prescription drugs ($959 vs. $906), and significantly lower costs attributed to institutional inpatient costs ($455 vs. $504), and durable medical equipment ($81 vs. $86).Older adults with breast cancer who received rehabilitation services had higher cost responsibility during the second year following diagnosis compared to those who did not. Future work is needed to examine the relationship between rehabilitation and out-of-pocket costs across longer periods of time and in conjunction with perceived benefit.Copyright © 2024. Published by Elsevier Inc.